Analyst Speak: 

“The Global Chagas Disease Management Market was valued around US$ XX Mn by 2018 and growing at a significant CAGR of XX% over next seven years 2019-2025 owing to growing incidence of chagas disease due to unhygienic conditions”

The global chagas disease management market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Factors which are influencing the market growth are growing investments in the field of research and development of new products, increasing prevalence of chagas disease owing to unhygienic conditions and increase in the chagas disease population. However, lack of awareness about the treatment of Chagas disease, very limited number of products approved and supply chain issues with chagas disease drugs are hampering the market growth.

Global chagas disease management market segmented on the basis of treatment type, drug type, distribution channel and region.

Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=15817

Benznidazole Dominate the Global Chagas Disease Management Market

Based on drug type, global chagas disease management market segmented into benznidazole and nifurtimox. Benznidazole segment held considerable market growth during estimated period. Benznidazole is typically used as treatment for Chagas disease. Benznidazole is indicated in pediatric patients 2 to 12 years of age for the treatment of Chagas disease. Benznidazole prominently reduce the parasitemia, which constitutes an important factor linked to vertical transmission. Early usage of benznidazole in Chagas disease treatment results in better clinical and parasitological outcomes.

North America Leads the Global Chagas Disease Management market 

PBI’s global chagas disease management market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America and Europe are the key markets for chagas disease management. North America dominated the market revenue share for Chagas disease management owing to rising prevalence and incidence of Chagas disease in the region. According to CDC, the prevalence of Chagas disease in North America was around 300,000 people in 2016. Latin America is expected to grow with a significant CAGR owing to increasing prevalence of Chagas disease in the region. According to WHO, around 8 million people are suffering from Chagas disease.

Strategic Collaboration are the Key Strategies Adopted by Market Players 

Global chagas disease management market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. In March 2017, Daiichi Sankyo Company Limited and Drugs for Neglected Diseases initiative (DNDi) are collaborated to form a joint research with regard to a new research program, the hit-to-lead project to develop the drugs for Chagas disease and leishmaniasis.

Key player’s profiles in the report are Novartis AG (Switzerland), Laboratorio Elea S.A.C.I.F. y A (Argentina), Kancera AB (Sweden), KaloBios Pharmaceuticals, Inc. (U.S.), Grupo Praxis Pharmaceutical

SA (Spain), GlaxoSmithKline Plc. (U.K), Eisai Co Ltd (Japan), Daiichi Sankyo Company Ltd (Japan), Bayer AG (Germany) and AstraZeneca (U.K).

For More Information @ https://www.precisionbusinessinsights.com/market-reports/chagas-disease-management-market/

Precision Business Insights (PBI) in its report titled “Global Chagas Disease Management Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market.

Detailed Segmentation 

By Drug Type

Benznidazole
Nifurtimox
By Treatment Type

Antiparasitic treatment
Symptomatic treatment
By Distribution Channel

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Geography

North America

US
Canada
Europe

Germany
France
UK
Italy
Spain
Russia
Poland
Rest of Europe
Asia-Pacific

Japan
China
India
Australia & New Zealand
ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
South Korea
Rest of Asia-Pacific
Latin America

Brazil
Mexico
Argentina
Rest of Latin America
Middle East and Africa (MEA)

Gulf Cooperation Council (GCC) Countries
Israel
South Africa
Rest of MEA
About Us:
 
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.
 
Contact Us:
 
Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights